Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Chinese Patent Office
Daiichi Sankyo
Citi
Colorcon
Teva
Medtronic
Harvard Business School
Baxter

Generated: January 20, 2018

DrugPatentWatch Database Preview

MIACALCIN Drug Profile

« Back to Dashboard

When do Miacalcin patents expire, and what generic alternatives are available?

Miacalcin is a drug marketed by Mylan Ireland Ltd and is included in two NDAs.

The generic ingredient in MIACALCIN is calcitonin salmon. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
Drug patent expirations by year for MIACALCIN
Pharmacology for MIACALCIN
Ingredient-typeCalcitonin
Drug ClassCalcitonin

US Patents and Regulatory Information for MIACALCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Ireland Ltd MIACALCIN calcitonin salmon INJECTABLE;INJECTION 017808-001 Jul 3, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Ireland Ltd MIACALCIN calcitonin salmon INJECTABLE;INJECTION 017808-002 Mar 29, 1991 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Ireland Ltd MIACALCIN calcitonin salmon SPRAY, METERED;NASAL 020313-002 Aug 17, 1995 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for MIACALCIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Ireland Ltd MIACALCIN calcitonin salmon SPRAY, METERED;NASAL 020313-002 Aug 17, 1995 ➤ Subscribe ➤ Subscribe
Mylan Ireland Ltd MIACALCIN calcitonin salmon SPRAY, METERED;NASAL 020313-002 Aug 17, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Healthtrust
Mallinckrodt
Queensland Health
Dow
Novartis
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot